THE CLINICAL PRESENTATION OF SUBCLINICAL HYPOTHYROIDISM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS ASSOCIATED WITH OBESITY, ITS IMPACT ON CARDIOVASCULAR RISK, AND WAYS OF ITS CORRECTION.

Autor: Griadil, Taras I., Chopey, Ivan V., Chubirko, Ksenia I., Feysa, Snizhana V.

Publikováno v: Wiadomości Lekarskie; Oct2021, Vol. 74 Issue 10, p2634-2639, 6p

COMPARISON OF THE EFFECT OF DAPAGLIFLOZIN ON CONTRAST TO STANDARD THERAPY OF THE PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CONCOMITANT OBESITY, THEIR EFFECT ON LABORATORY AND ANTHROPOMETRIC PARAMETERS.

Autor: Griadil, Taras I., Chopey, Ivan V., Debreceni, Kristian O., Hechko, Mykhaylo M., Mykhalko, Yaroslav O., Feysa, Snizhana V.

Publikováno v: Wiadomości Lekarskie; 2020, Vol. 73 Issue 3, p457-461, 5p

IS FECAL CALPROTECTIN DETERMINATION USEFUL FOR PATIENTS WITH METABOLIC ASSOCIATED FATTY LIVER DISEASE?

Autor: Feysa SV; STATE HIGHER EDUCATIONAL ESTABLISHMENT 'UZHHOROD NATIONAL UNIVERSITY', UZHHOROD, UKRAINE., Pushkarenko OA; STATE HIGHER EDUCATIONAL ESTABLISHMENT 'UZHHOROD NATIONAL UNIVERSITY', UZHHOROD, UKRAINE., Rudakova SO; STATE HIGHER EDUCATIONAL ESTABLISHMENT 'UZHHOROD NATIONAL UNIVERSITY', UZHHOROD, UKRAINE., Varvarynets AV; STATE HIGHER EDUCATIONAL ESTABLISHMENT 'UZHHOROD NATIONAL UNIVERSITY', UZHHOROD, UKRAINE.

Publikováno v: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego [Pol Merkur Lekarski] 2023; Vol. 51 (4), pp. 330-333.